An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Cookie Johnson stood by her husband Magic's side after he was diagnosed as HIV positive, and the two have been fierce ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...